Cargando…
Dramatic Response of Leptomeningeal Carcinomatosis to Nivolumab in PD-L1 Highly Expressive Non-small Cell Lung Cancer: A Case Report
In a patient who had been diagnosed of located squamous cell lung carcinoma, pneumonectomy, and adjuvant chemotherapy were performed. Brain recurrence and subsequent lung metastatic disease were uncontrolled by neurosurgery, holocranial radiotherapy, and first-line chemotherapy. In August 2015, appe...
Autores principales: | Arias Ron, David, Labandeira, Carmen M., Areses Manrique, María Carmen, Sampedro Domarco, Paula, Abdulkader, Ihab, García-Mata, Jesús, Rolfo, Christian, González-Rivas, Diego, Fírvida, Jose Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743439/ https://www.ncbi.nlm.nih.gov/pubmed/31552167 http://dx.doi.org/10.3389/fonc.2019.00819 |
Ejemplares similares
-
Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis
por: Brastianos, Priscilla K., et al.
Publicado: (2021) -
Recent Advancements of Treatment for Leptomeningeal Carcinomatosis
por: Gwak, Ho-Shin, et al.
Publicado: (2015) -
Leptomeningeal Carcinomatosis with Delayed Ocular Manifestations
por: Czyz, Craig, et al.
Publicado: (2021) -
Leptomeningeal carcinomatosis or ischemic cerebrovascular disease?
por: Eran, Ayelet, et al.
Publicado: (2021) -
Multiple Dural Tuberculomas Presenting as Leptomeningeal Carcinomatosis
por: Kocaeli, Hasan, et al.
Publicado: (2011)